Publication | Closed Access
Monoclonal anti-A and anti-B: development as cost-effective reagents.
33
Citations
0
References
1982
Year
MedicineCost-effective ReagentsImmunologyAnti-cancer AgentDrug DevelopmentPharmacology
No additional data available for this publication yet. Check back later!